BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1522 related articles for article (PubMed ID: 26604651)

  • 1. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
    World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the risk factors of hepatocellular carcinoma and survival analysis for cirrhosis after transjugular intrahepatic portosystemic shunt in treating portal hypertension.
    Wei J; Li H; Li C
    J Cancer Res Ther; 2018; 14(4):826-832. PubMed ID: 29970660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transjugular Intrahepatic Portosystemic Shunt for Portal Hypertension in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
    Qiu B; Li K; Dong X; Liu FQ
    Cardiovasc Intervent Radiol; 2017 Sep; 40(9):1372-1382. PubMed ID: 28488102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis.
    Zhao JB; Feng C; Zhu QH; He XF; Li YH; Chen Y
    World J Gastroenterol; 2014 Feb; 20(6):1602-7. PubMed ID: 24587637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
    Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
    World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
    World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.
    Siramolpiwat S
    World J Gastroenterol; 2014 Dec; 20(45):16996-7010. PubMed ID: 25493012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma.
    Bettinger D; Knüppel E; Euringer W; Spangenberg HC; Rössle M; Thimme R; Schultheiß M
    Aliment Pharmacol Ther; 2015 Jan; 41(1):126-36. PubMed ID: 25329493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial.
    Perarnau JM; Le Gouge A; Nicolas C; d'Alteroche L; Borentain P; Saliba F; Minello A; Anty R; Chagneau-Derrode C; Bernard PH; Abergel A; Ollivier-Hourmand I; Gournay J; Ayoub J; Gaborit C; Rusch E; Giraudeau B;
    J Hepatol; 2014 May; 60(5):962-8. PubMed ID: 24480619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of transjugular intrahepatic portosystemic shunt combined with transcatheter embolization/chemoembolization in hepatocellular carcinoma with portal hypertension and arterioportal shunt.
    Lu HL; Xuan FF; Luo YC; Qin X
    Abdom Radiol (NY); 2021 Nov; 46(11):5417-5427. PubMed ID: 34302511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
    Teng D; Zuo H; Liu L; Dong J; Ding L
    Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
    Berres ML; Lehmann J; Jansen C; Görtzen J; Meyer C; Thomas D; Zimmermann HW; Kroy D; Schumacher F; Strassburg CP; Sauerbruch T; Trautwein C; Wasmuth HE; Trebicka J
    Liver Int; 2016 Mar; 36(3):386-94. PubMed ID: 26212075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome using the fluency stent graft for transjugular intrahepatic portosystemic shunt in patients with portal hypertension.
    Wu X; Ding W; Cao J; Fan X; Li J
    Am Surg; 2013 Mar; 79(3):305-12. PubMed ID: 23461959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
    Li ZP; Wang SS; Wang GC; Huang GJ; Cao JQ; Zhang CQ
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of technical parameters on transjugular intrahepatic portosystemic shunts utilizing stent grafts.
    Andring B; Kalva SP; Sutphin P; Srinivasa R; Anene A; Burrell M; Xi Y; Pillai AK
    World J Gastroenterol; 2015 Jul; 21(26):8110-7. PubMed ID: 26185383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular intrahepatic portosystemic shunt placement before abdominal intervention in cirrhotic patients with portal hypertension: lessons from a pilot study.
    Fares N; Robic MA; Péron JM; Muscari F; Otal P; Suc B; Vinel JP; Bureau C
    Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):21-26. PubMed ID: 29049129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients.
    He FL; Wang L; Yue ZD; Zhao HW; Liu FQ
    World J Gastroenterol; 2014 Sep; 20(33):11835-9. PubMed ID: 25206289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.